Cargando…
Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data
Economic evaluations conducted alongside randomized controlled trials are a popular vehicle for generating high-quality evidence on the incremental cost-effectiveness of competing health care interventions. Typically, in these studies, resource use (and by extension, economic costs) and clinical (or...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295965/ https://www.ncbi.nlm.nih.gov/pubmed/33813933 http://dx.doi.org/10.1177/0272989X211003880 |
_version_ | 1783725528090411008 |
---|---|
author | Achana, Felix Gallacher, Daniel Oppong, Raymond Kim, Sungwook Petrou, Stavros Mason, James Crowther, Michael |
author_facet | Achana, Felix Gallacher, Daniel Oppong, Raymond Kim, Sungwook Petrou, Stavros Mason, James Crowther, Michael |
author_sort | Achana, Felix |
collection | PubMed |
description | Economic evaluations conducted alongside randomized controlled trials are a popular vehicle for generating high-quality evidence on the incremental cost-effectiveness of competing health care interventions. Typically, in these studies, resource use (and by extension, economic costs) and clinical (or preference-based health) outcomes data are collected prospectively for trial participants to estimate the joint distribution of incremental costs and incremental benefits associated with the intervention. In this article, we extend the generalized linear mixed-model framework to enable simultaneous modeling of multiple outcomes of mixed data types, such as those typically encountered in trial-based economic evaluations, taking into account correlation of outcomes due to repeated measurements on the same individual and other clustering effects. We provide new wrapper functions to estimate the models in Stata and R by maximum and restricted maximum quasi-likelihood and compare the performance of the new routines with alternative implementations across a range of statistical programming packages. Empirical applications using observed and simulated data from clinical trials suggest that the new methods produce broadly similar results as compared with Stata’s merlin and gsem commands and a Bayesian implementation in WinBUGS. We highlight that, although these empirical applications primarily focus on trial-based economic evaluations, the new methods presented can be generalized to other health economic investigations characterized by multivariate hierarchical data structures. |
format | Online Article Text |
id | pubmed-8295965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-82959652021-08-06 Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data Achana, Felix Gallacher, Daniel Oppong, Raymond Kim, Sungwook Petrou, Stavros Mason, James Crowther, Michael Med Decis Making Original Research Articles Economic evaluations conducted alongside randomized controlled trials are a popular vehicle for generating high-quality evidence on the incremental cost-effectiveness of competing health care interventions. Typically, in these studies, resource use (and by extension, economic costs) and clinical (or preference-based health) outcomes data are collected prospectively for trial participants to estimate the joint distribution of incremental costs and incremental benefits associated with the intervention. In this article, we extend the generalized linear mixed-model framework to enable simultaneous modeling of multiple outcomes of mixed data types, such as those typically encountered in trial-based economic evaluations, taking into account correlation of outcomes due to repeated measurements on the same individual and other clustering effects. We provide new wrapper functions to estimate the models in Stata and R by maximum and restricted maximum quasi-likelihood and compare the performance of the new routines with alternative implementations across a range of statistical programming packages. Empirical applications using observed and simulated data from clinical trials suggest that the new methods produce broadly similar results as compared with Stata’s merlin and gsem commands and a Bayesian implementation in WinBUGS. We highlight that, although these empirical applications primarily focus on trial-based economic evaluations, the new methods presented can be generalized to other health economic investigations characterized by multivariate hierarchical data structures. SAGE Publications 2021-04-05 2021-08 /pmc/articles/PMC8295965/ /pubmed/33813933 http://dx.doi.org/10.1177/0272989X211003880 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Articles Achana, Felix Gallacher, Daniel Oppong, Raymond Kim, Sungwook Petrou, Stavros Mason, James Crowther, Michael Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data |
title | Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data |
title_full | Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data |
title_fullStr | Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data |
title_full_unstemmed | Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data |
title_short | Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data |
title_sort | multivariate generalized linear mixed-effects models for the analysis of clinical trial–based cost-effectiveness data |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295965/ https://www.ncbi.nlm.nih.gov/pubmed/33813933 http://dx.doi.org/10.1177/0272989X211003880 |
work_keys_str_mv | AT achanafelix multivariategeneralizedlinearmixedeffectsmodelsfortheanalysisofclinicaltrialbasedcosteffectivenessdata AT gallacherdaniel multivariategeneralizedlinearmixedeffectsmodelsfortheanalysisofclinicaltrialbasedcosteffectivenessdata AT oppongraymond multivariategeneralizedlinearmixedeffectsmodelsfortheanalysisofclinicaltrialbasedcosteffectivenessdata AT kimsungwook multivariategeneralizedlinearmixedeffectsmodelsfortheanalysisofclinicaltrialbasedcosteffectivenessdata AT petroustavros multivariategeneralizedlinearmixedeffectsmodelsfortheanalysisofclinicaltrialbasedcosteffectivenessdata AT masonjames multivariategeneralizedlinearmixedeffectsmodelsfortheanalysisofclinicaltrialbasedcosteffectivenessdata AT crowthermichael multivariategeneralizedlinearmixedeffectsmodelsfortheanalysisofclinicaltrialbasedcosteffectivenessdata |